share_log

Goldman Sachs Maintains Neutral on Eli Lilly and Co, Raises Price Target to $723

Benzinga ·  Apr 11 09:05

Goldman Sachs analyst Chris Shibutani maintains Eli Lilly and Co (NYSE:LLY) with a Neutral and raises the price target from $650 to $723.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment